CD274 and neoplasm: Since the above findings suggested that GOLM1 upregulates PD-L1 expression on macrophages and limits the anti-tumor T cell response, we sought to determine whether inhibiting TAM infiltration combined with anti-PD-L1 immunotherapy relieves T cell suppression and inhibits tumor growth.